LUBRAMINE Trademark

Trademark Overview


On Wednesday, September 5, 2007, a trademark application was filed for LUBRAMINE with the United States Patent and Trademark Office. The USPTO has given the LUBRAMINE trademark a serial number of 77271537. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 14, 2009. This trademark is owned by Goldshield Group Plc. The LUBRAMINE trademark is filed in the Pharmaceutical Products category with the following description:

Adhesives for dentistry and dental technical purposes; All purpose disinfecting and deodorizing preparations; Alloys of precious metal for use in dentistry and dentistry technology; Anesthetics for surgical and non-surgical use; Anti-arthritic compositions and preparations; Anti-inflammatory and antipyretic preparations; Antibacterial/antimicrobial tape for the purpose of destroying bacteria, mold and mildew; Antimicrobial coatings to treat the growth of mold, mildew, bacteria and fungus on various surfaces; Antimicrobial preparations for inhibiting microbiological decomposition in food, beverages, animal feed and pharmaceuticals; Antimicrobial preservatives for cosmetics and pharmaceuticals; Bacterial and bacteriological preparations for medical or veterinary purposes; Bacteriostats for medicinal, dental and veterinary use; Base metals and alloys for dentistry use; Biological and chemical preparations and reagents for medical or veterinary use; Biomedical compounds, namely, peptide su...
lubramine

General Information


Serial Number77271537
Word MarkLUBRAMINE
Filing DateWednesday, September 5, 2007
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 14, 2009
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 20, 2008

Trademark Statements


Goods and ServicesAdhesives for dentistry and dental technical purposes; All purpose disinfecting and deodorizing preparations; Alloys of precious metal for use in dentistry and dentistry technology; Anesthetics for surgical and non-surgical use; Anti-arthritic compositions and preparations; Anti-inflammatory and antipyretic preparations; Antibacterial/antimicrobial tape for the purpose of destroying bacteria, mold and mildew; Antimicrobial coatings to treat the growth of mold, mildew, bacteria and fungus on various surfaces; Antimicrobial preparations for inhibiting microbiological decomposition in food, beverages, animal feed and pharmaceuticals; Antimicrobial preservatives for cosmetics and pharmaceuticals; Bacterial and bacteriological preparations for medical or veterinary purposes; Bacteriostats for medicinal, dental and veterinary use; Base metals and alloys for dentistry use; Biological and chemical preparations and reagents for medical or veterinary use; Biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; Biscuits, bread, bread rolls, cakes, cereal products, confectionery, crackers, noodles, fish sauce, relish, sauces, cereal-based snack-foods and prepared dietary items that are gluten-free to accommodate special medical and health conditions; Bonding and primer materials for dental purposes; Carpet fresheners and odor eliminators; Cedar wood for use as a clothing protector and/or deodorizer; Composite materials for dental and dental technical purposes; Corn and callus creams; Dental resin for temporary bridges, crowns and veneers; Deodorizing products, namely, all purpose deodorizer preparations for household, commercial and industrial use; Diagnostic agents, preparations and substances for medical purposes; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic preparations for medical and veterinary use; Diagnostic reagents and contrast media for medical use; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Dietary and nutritional supplements; Dietary and nutritionally fortified food products adapted for medical use; Dissolvable strips to stop bleeding from minor cuts and grazes; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Embedding material for dental and dental technical purposes; Eye pillows containing aromatic substances for relief from headaches, insomnia and sinus discomfort; Fish, pickles, preserved olives and dietary foods and food-items that are gluten-free to accommodate special medical and health conditions; Fissure sealant for dental and dental technical purposes; Fluid for the topical fluoridation of tooth enamel and decay prevention; Gases for medical and dental use; Germicides and fungicides; Gluten-free food to accommodate special medical and health conditions; Herbal anti-itch and sore skin ointment for pets; Herbal products, namely, aromatherapy packs containing herbs used for relief from headaches, insomnia and sinus discomfort; Herbicides, insecticides, pesticides and fungicides for home, garden and lawn use and for professional use; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Material for repairing teeth and for dental crowns and bridges; Material for tooth crowns and tooth bridges for dental and dental technical purposes; Materials for crowns and bridges for dental use and for oral prophylaxis; Materials for dental fillings and for sealing purposes; Meal replacement and dietary supplement drink mixes; Medical cleansers for skin and wounds; Medical diagnostic reagents and assays for testing of body fluids; Medicated diaper rash ointments and lotions; Medicated mouth care and treatment preparations; Medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels; Medicinal preparations for the mouth and as sprays; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets; Microbiocides for industrial and institutional manufacturing processes and wastewater applications; Mold inhibitors for treating mold growth in and around buildings; Multipurpose medicated antibiotic cream, analgesic balm and mentholated salve; Nasal and oral spray preparations for use as central nervous system stimulants; Nucleic acid sequences and chemical reagents for medical and veterinary purposes; Nutritional additives for medical purposes for use in foods and dietary supplements for human consumption; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases; for the treatment of bacteria-based diseases; for the treatment of diabetes, anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for chloasma; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for pregnancy blemishes; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases and asthma; Plant extracts for medical, veterinary and pharmaceutical purposes; Precious metals and precious metal alloys for dentistry use; Preparations to prevent nail-biting and thumb-sucking; Products and preparations for cleansing the skin for medical use; Protein reduced and gluten free food for medical purposes; Radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; Reagents and media for medical and veterinary diagnostic purposes; Rubbing compound for medical and/or therapeutic use; Sanitizers for use in institutional and industrial areas; Sinus pillows containing aromatic substances for relief from headaches, insomnia and sinus discomfort; Soy protein for use as a nutritional ingredient in various powdered and ready-to-drink beverages; Strip used to anesthetize the superficial layers of the cornea and also containing preparations to diagnose defects therein using a staining dye; Testing kits containing peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; Thyroid and para-thyroid hormone preparations; Vitamin and mineral formed and packaged as bars; Vitamin and mineral preparations for medical use; Vitamin and mineral preparations for use as ingredients in the food and pharmaceutical industry; Vitamin and mineral supplements

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 10, 2007
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGoldshield Group Plc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCroydon Surrey CR00XT
GB

Party NameGoldshield Group Plc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCroydon Surrey CR00XT
GB

Trademark Events


Event DateEvent Description
Monday, September 14, 2009ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 14, 2009ABANDONMENT - NO USE STATEMENT FILED
Thursday, November 13, 2008EXTENSION 1 GRANTED
Monday, November 10, 2008EXTENSION 1 FILED
Wednesday, November 12, 2008CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 10, 2008TEAS EXTENSION RECEIVED
Tuesday, August 12, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Monday, July 7, 2008TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 20, 2008PUBLISHED FOR OPPOSITION
Friday, May 16, 2008UNDELIVERABLE MAIL - NO ACTION TAKEN
Wednesday, April 30, 2008NOTICE OF PUBLICATION
Saturday, April 12, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, April 12, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 25, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 25, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 25, 2008ASSIGNED TO LIE
Wednesday, March 12, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 31, 2008NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, January 31, 2008FINAL REFUSAL E-MAILED
Thursday, January 31, 2008FINAL REFUSAL WRITTEN
Wednesday, January 2, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 2, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 2, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 12, 2007NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 12, 2007NON-FINAL ACTION E-MAILED
Wednesday, December 12, 2007NON-FINAL ACTION WRITTEN
Saturday, December 8, 2007ASSIGNED TO EXAMINER
Monday, September 10, 2007NEW APPLICATION ENTERED IN TRAM